HRT Financial’s Aethlon Medical AEMD Stock Holding History

HRT Financial’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59K	Buy	+14,549	New	+$151K	﹤0.01%	3729
2025 Q4	–	Sell	-2,612	Closed	-$97K	–	3109
2025 Q3	$97K	Buy	+2,612	New	+$151K	﹤0.01%	2527
2025 Q2	–	Sell	-50	Closed	-$7K	–	2519
2025 Q1	$7K	Buy	+50	New	+$11.6K	﹤0.01%	2374
2024 Q3	–	Sell	-25	Closed	-$5K	–	2337
2024 Q2	$5K	Buy	+25	New	+$9.85K	﹤0.01%	2039
2023 Q4	–	Sell	-4	Closed	-$3K	–	2243
2023 Q3	$3K	Buy	+4	New	+$5.13K	﹤0.01%	2213
2023 Q2	–	Sell	-27	Closed	-$41K	–	2376
2023 Q1	$41K	Buy	27 +1	+4%	+$1.88K	﹤0.01%	2141
2022 Q4	$28K	Buy	+26	New	+$47.4K	﹤0.01%	2149

Other funds holding AEMD

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HRT Financial's AEMD Position: Q2 2026 in Review

HRT Financial opened a new position in Aethlon Medical (AEMD) in Q2 2026: 14,549 shares worth $59K. The stake represents ﹤0.01% of the portfolio and ranks #3729 among its holdings. This is a return to the name: HRT Financial previously reported a position in AEMD as recently as Q3 2025.

HRT Financial first reported a position in AEMD in Q4 2022 and has held it in 7 quarters since. The position peaked at $97K in Q3 2025. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

HRT Financial held 14,549 shares of Aethlon Medical worth $59K as of Q2 2026.
Aethlon Medical was a new HRT Financial position in Q2 2026.
Aethlon Medical made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3729 holding.
HRT Financial first reported a position in Aethlon Medical in Q4 2022 and has held it in 7 quarters since.
HRT Financial's Aethlon Medical position peaked at $97K in Q3 2025.
15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.